Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term randomized. Found 19 abstracts

Colt DG, Andtbacka R, Anker CJ, Bichakjian CK, Carson WE, Daud A, Dilawari RA, DiMaio D, Guild V, Halpern AC, Hodi FS, Kelley MC, Khushalani NI, Kudchadkar RR, Lange JR, Lind A, Martini MC, Olszanski AJ, Pruitt SK, Ross MI, Swetter SM, Tanabe KK, Thompson JA, Trisal V, Urist MM. Melanoma. Journal of the National Comprehensive Cancer Network. 2012 Mar;10(3):366-400.   PMCID: not NIH funded
Ettinger DS, Akerley W, Borghaei H, Chang A, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Ganti AK, Govindan R, Grannis FW, Horn L, Jahan TM, Jahanzeb M, Kessinger A, Komaki R, Kong FM, Kris MG, Krug LM, Lennes IT, Loo BW, Martins R, O'Malley J, Osarogiagbon RU, Otterson GA, Patel JD, Pinder-Schenck M, Pisters KM, Reckamp K, Riely GJ, Rohren E, Swanson SJ, Wood DE, Yang SC. Malignant Pleural Mesothelioma. Journal of the National Comprehensive Cancer Network. 2012 Jan;10(1):26-41.   PMCID: not NIH funded
Ettinger DS, Armstrong DK, Barbour S, Berger MJ, Bierman PJ, Bradbury B, Ellis G, Kirkegaard S, Kloth DD, Kris MG, Lim D, Michaud LB, Nabati L, Noonan K, Rugo HS, Siler D, Sorscher SM, Stelts S, Stucky-Marshall L, Todaro B, Urba SG. Antiemesis Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. 2012 Apr;10(4):456-85.   PMCID: not NIH funded
Mohler JL, Armstrong AJ, Bahnson RR, Boston B, Busby JE, D'Amico AV, Eastham JA, Enke CA, Farrington T, Higano CS, Horwitz EM, Kantoff PW, Kawachi MH, Kuettel M, Lee RJ, MacVicar GR, Malcolm AW, Miller D, Plimack ER, Pow-Sang JM, Roach M, Rohren E, Rosenfeld S, Srinivas S, Strope SA, Tward J, Twardowski P, Walsh PC, Ho M, Shead DA. Prostate Cancer, Version 3.2012 Featured Updates to the NCCN Guidelines. Journal of the National Comprehensive Cancer Network. 2012 Sep;10(9):1081-7.   PMCID: Not NIH Funded
Streiff MB, Bockenstedt PL, Cataland SR, Chesney C, Eby C, Fanikos J, Fogarty PF, Gao SW, Garcia-Aguilar J, Goldhaber SZ, Hassoun H, Hendrie P, Holmstrom B, Jones KA, Kuderer N, Lee JT, Millenson MM, Neff AT, Ortel TL, Smith JL, Yee GC, Zakarija A, Nccn Clinical Practice Guidelines. Venous Thromboembolic Disease. Journal of the National Comprehensive Cancer Network. 2011 Jul;9(7):714-77.   PMCID: not NIH funded
Partridge EE, Abu-Rustum NR, Campos SM, Fahey PJ, Farmer M, Garcia RL, Giuliano A, Jones HW, Lele SM, Lieberman RW, Massad SL, Morgan MA, Reynolds RK, Rhodes HE, Singh DK, Smith-McCune K, Teng N, Trimble CL, Valea F, Wilczynski S. Cervical Cancer Screening. Journal of the National Comprehensive Cancer Network. 2010 Dec;8(12):1358-86.   PMCID: not NIH funded
Coit DG, Andtbacka R, Bichakjian CK, Dilawari RA, DiMaio D, Guild V, Halpern AC, Hodi FS, Kashani-Sabet M, Lange JR, Lind A, Martin L, Martini MC, Pruitt SK, Ross MI, Sener SF, Swetter SM, Tanabe KK, Thompson JA, Trisal V, Urist MM, Weber J, Wong MK. Melanoma. Journal of the National Comprehensive Cancer Network. 2009 Mar;7(3):250-75.   PMCID: not NIH funded
Engstrom PF, Arnoletti JP, Benson AB, Chen YJ, Choti MA, Cooper HS, Covey A, Dilawari RA, Early DS, Enzinger PC, Fakih MG, Fleshman J, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Lin E, Mulcahy MF, Rao S, Ryan DP, Saltz L, Shibata D, Skibber JM, Sofocleous C, Thomas J, Venook AP, Willett C. Colon Cancer. Journal of the National Comprehensive Cancer Network. 2009 Sep;7(8):778-831.   PMCID: no NIH - Practice Guideline
Kuban DA, Tucker SL, Dong L, Starkschall G, Huang EE, Cheung MR, Lee AK, Pollack A. Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer. International Journal of Radiation Oncology Biology Physics. 2008 Jan;70(1):67-74.
Ershoff DH, Quinn VP, Boyd NR, Stern J, Gregory M, Wirtschafter D. The Kaiser Permanente prenatal smoking-cessation trial - When more isn't better, what is enough?. American Journal of Preventive Medicine. 1999 Oct;17(3):161-8.
Fowble B. Postmastectomy radiation in patients with one to three positive axillary nodes receiving adjuvant chemotherapy: An unresolved issue. Seminars in Radiation Oncology. 1999 Jul;9(3):230-40.
Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, Vogel V, Robidoux A, Dimitrov N, Atkins J, Daly M, Wieand S, Tan-Chiu E, Ford L, Wolmark N. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study. Journal of the National Cancer Institute. 1998 Sep 16;90(18):1371-88.
Burke W, Daly M, Garber J, Botkin J, Kahn MJ, Lynch P, McTierman A, Offit K, Perlman J, Petersen G, Thomson E, Varricchio C. Recommendations for follow-up care of individuals with an inherited predisposition to cancer .2. BRCA1 and BRCA2. JAMA-Journal of the American Medical Association. 1997 Mar 26;277(12):997-1003.
Abrams DB, Orleans CT, Niaura RS, Goldstein MG, Prochaska JO, Velicer W. Integrating individual and public health perspectives for treatment of tobacco dependence under managed health care: A combined stepped-care and matching model. Annals of Behavioral Medicine. 1996 Jan;18(4):290-304.
Rosvold E. Chemoprevention of lung cancer. Current Problems in Cancer. 1996 Jul;20(4):266-71.
Langer CJ, Leighton JC, Comis RL, Odwyer PJ, McAleer CA, Bonjo CA, Engstrom PF, Litwin S, Ozols RF. Paclitaxel and Carboplatin in Combination in the Treatment of Advanced Non-Small-Cell Lung-Cancer - a Phase-Ii Toxicity, Response, and Survival Analysis. Journal of Clinical Oncology. 1995 Aug;13(8):1860-70.
Roth BJ, Dreicer R, Einhorn LH, Neuberg D, Johnson DH, Smith JL, Hudes GR, Schultz SM, Loehrer PJ. Significant Activity of Paclitaxel in Advanced Transitional- Cell Carcinoma of the Urothelium - a Phase-Ii Trial of the Eastern-Cooperative-Oncology-Group. Journal of Clinical Oncology. 1994 Nov;12(11):2264-70.
Ozols RF. Advances in the Chemotherapy of Gynecologic Malignancies. Hematological Oncology. 1992 Jan;10(1):43-51.
Young RC. Etoposide in the Treatment of Non-Hodgkins-Lymphomas. Seminars in Oncology. 1992 Dec;19(6):19-25.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term randomized

randomized trial NCCN Clinical Practice Guidelines chemotherapy NCCN Guidelines controlled-trial cooperative-oncology-group positron-emission-tomography cancer therapy surgery postmenopausal women metastatic lymph-node biopsy biopsy smokers combination chemotherapy malignant-melanoma radiation therapy cisplatin primary cutaneous melanoma follow-up high-risk melanoma metastatic colorectal-cancer liquid-based dose human papillomavirus testing neoplasm recurrence chemotherapy-induced Papanicolaou test malignant pleural dose hemithoracic radiation interventions colonic neoplasms adjuvant chemotherapy anticoagulation surgical excision squamous-cell carcinoma vitamin-e acupuncture-point stimulation prevention long-term survival bone-marrow transplantation budd-chiari-syndrome phase-iii RTOG insitu intraepithelial multicenter phase-ii colony-stimulating factor 1993 evallier b-british journal of cancer-v68-p176 human-papillomavirus type-16 clinical-trial placebo-controlled trial 1990 mulder phm-annals of internal medicine-v113-p834 FAILURE fluorouracil plus leucovorin term follow-up MEN risk beta- high-dose interferon-alpha-2b dna- lymph node dissection cyto-toxicity controlled trial EORTC early-stage melanoma nitrate deep venous young-women fecal occult blood lymph-node micrometastases receptor antagonists multidrug resistance smoking cessation intensity-modulated radiotherapy carotene radiation sensitizer cancer screening fetal ERA procedure cervical-cancer chemotherapy-induced nausea undetermined significance recombinant interleukin-2 therapy vena-cava filters intraperitoneal cisplatin phase-iii trial lung-cancer pulmonary embolism cancer-chemotherapy taxol experience external beam treatment thromboembolism 5-fluorouracil ovarian-cancer pemetrexed plus cisplatin breast self-examination postoperative radiotherapy antiemesis oncology-group adenocarcinoma moderately-emetogenic chemotherapy loop electrosurgical excision creatinine clearance 1993 n jkl-journal of dermatologic surgery and oncology-v19-p985 repair modified radical-mastectomy oxaliplatin-based poor-prognosis metastases deep-vein skin and vomiting 1994 bbia v-cancer-v74-p1945 trimodality therapy high-dose international normalized ratio cold-knife conization fagerstrom tolerance questionnaire controlled-trials thrombosis warfarin NK-1 prostate cancer large-cell lymphoma prenatal care plasma-lipids radiation-therapy dose intensity pregnant-women pathology heparin transplantation excision procedure cell quality-of-life cognitive behavior therapy mortality prophylaxis TOXICITY pleural effusion isolated limb perfusion maternal smoking urinary-tract stage-iii melanoma
Last updated on Wednesday, February 05, 2020